Ignite Creation Date:
2024-05-06 @ 2:57 PM
Last Modification Date:
2024-10-26 @ 1:40 PM
Study NCT ID:
NCT04476017
Status:
COMPLETED
Last Update Posted:
2023-07-28
First Post:
2020-07-15
Brief Title:
A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Parkinsons Disease Mild Cognitive Impairment PD-MCI
Sponsor:
Sage Therapeutics
Organization:
Sage Therapeutics
Study Overview
Official Title:
An Open-Label Evaluation of the Safety and Tolerability of SAGE-718 in Participants With Parkinsons Disease Mild Cognitive Impairment
Status:
COMPLETED
Status Verified Date:
2023-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary purpose of this two-part study was to evaluate the safety and tolerability of SAGE-718 and its effects on cognitive neuropsychiatric and motor symptoms in participants with Parkinsons disease mild cognitive impairment PD-MCI
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None